Verweise von und zu Maculopapular cutaneous mastocytosis
Zurück zum ArtikelVerweise von anderen Artikeln
- Biopsy
- Brown man
- Darian sign
- Spot darker
- Galli-galli disease
- Facial erythema
- Histiocytosis benign cephalic
- Incontinentia pigmenti (Bloch-Sulzberger)
- Cutaneous mastocytosis of adulthood
- Cutaneous mastocytosis of childhood
- Cutaneous mastocytoma
- Diffuse cutaneous mastocytosis
- Cutaneous mastocytosis
- Advanced systemic mastocytosis
- Indolent systemic mastocytosis
- Systemic mastocytosis
- Nettleship's disease
- Nettleship syndrome
- Omalizumab
- Syringome disseminated
- Urticaria factitia
- Urticaria pigmentosa
- Urticaria pigmentosa bullosa
- Urticaria pigmentosa haemorrhagica
- Urticaria pigmentosa xanthelasmoidea
- Uva-1 therapy
- Xeroderma pigmentosum
Verweise zu anderen Artikeln
- Acetylsalicylic acid
- Antihistamines
- Antihistamines, h2-antagonists
- Antihistamines, systemic
- Bubble
- Cd117
- Cd25
- CD classification
- Cimetidine
- Darian sign
- Dimetinden
- Disodium cromoglicic acid
- Gels hydrophilic
- Glucocorticosteroids
- Glucorticosteroids topical
- Heparin
- Histamine
- Hydrocortisone
- Hydrocortisone cream 0.5-2.0% (w/o)
- Interleukin-31
- Interleukins
- Ketotifen
- Levocetirizine
- Cutaneous mastocytoma
- Diffuse cutaneous mastocytosis
- Maculopapular cutaneous mastocytosis
- Mastocytosis (overview)
- Advanced systemic mastocytosis
- Indolent systemic mastocytosis
- Systemic mastocytosis
- Omalizumab
- Polidocanol
- Polidocanol zinc oxide shaking mixture 3/5 or 10% (nrf 11.66.) [white/skin coloured].
- Prednisone
- Procaine
- Puva therapy
- Teleangiectasia macularis eruptiva perstans
- Tryptase
- Urticaria pigmentosa bullosa
- Urticaria pigmentosa, exanthematic
- Urticaria pigmentosa haemorrhagica
- Urticaria pigmentosa xanthelasmoidea
- Urticaria chronic spontaneous
- Cytokines